ES2196014T3 - Vectores de virus espumosos recombinantes para usos medicos y de diagtico y procedimiento de preparacion de vectores de virus espumosos recombinantes. - Google Patents

Vectores de virus espumosos recombinantes para usos medicos y de diagtico y procedimiento de preparacion de vectores de virus espumosos recombinantes.

Info

Publication number
ES2196014T3
ES2196014T3 ES94107918T ES94107918T ES2196014T3 ES 2196014 T3 ES2196014 T3 ES 2196014T3 ES 94107918 T ES94107918 T ES 94107918T ES 94107918 T ES94107918 T ES 94107918T ES 2196014 T3 ES2196014 T3 ES 2196014T3
Authority
ES
Spain
Prior art keywords
sparkling
viruses
preparation
recombinant
vometers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94107918T
Other languages
English (en)
Inventor
Meulen Volker Prof Dr Ter
Axel Dr Rethwilm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2196014T3 publication Critical patent/ES2196014T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/17011Spumavirus, e.g. chimpanzee foamy virus
    • C12N2740/17022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/17011Spumavirus, e.g. chimpanzee foamy virus
    • C12N2740/17041Use of virus, viral particle or viral elements as a vector
    • C12N2740/17043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/20Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/44Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/80Vectors comprising a special translation-regulating system from vertebrates
    • C12N2840/85Vectors comprising a special translation-regulating system from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Transplantation (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A LA PREPARACION DE NUEVOS SISTEMAS DE VECTORES QUE SE GENERAN MEDIANTE UNA RECOMBINACION IN VITRO, UTILIZANDO TECNICAS GENETICAS, DE ACIDOS NUCLEICOS A PARTIR DE ESPECIES DE VIRUS ESPUMOSOS Y DE ACIDO NUCLEICO EXOGENO Y SE PRODUCEN MEDIANTE CELULAS HUESPEDES ADECUADAS O MEDIANTE LINEAS CELULARES DE FUSION ALTERADAS DE FORMA RECOMBINANTE. LA PREPARACION RECOMBINANTE DE LINEAS CELULARES DE FUSION PARTICULARMENTE ADECUADAS TAMBIEN FORMA PARTE DE ESTA INVENCION. LA INVENCION SE CARACTERIZA POR LA TRANSFERENCIA SEGURA Y EFICIENTE A TRAVES DE VECTORES DE VIRUS ESPUMOSOS DE GENES TERAPEUTICOS O DE CUALQUIER OTRO TIPO DE GENES EN CELULAS EUCARIOTICAS.
ES94107918T 1993-06-03 1994-05-24 Vectores de virus espumosos recombinantes para usos medicos y de diagtico y procedimiento de preparacion de vectores de virus espumosos recombinantes. Expired - Lifetime ES2196014T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4318387A DE4318387A1 (de) 1993-06-03 1993-06-03 Rekombinante Foamy Virus Vektoren für medizinische und diagnostische Anwendungen sowie Verfahren zur Herstellung von rekombinanten Foamy Virus Vektoren

Publications (1)

Publication Number Publication Date
ES2196014T3 true ES2196014T3 (es) 2003-12-16

Family

ID=6489499

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94107918T Expired - Lifetime ES2196014T3 (es) 1993-06-03 1994-05-24 Vectores de virus espumosos recombinantes para usos medicos y de diagtico y procedimiento de preparacion de vectores de virus espumosos recombinantes.

Country Status (10)

Country Link
US (1) US5646032A (es)
EP (1) EP0632129B1 (es)
JP (2) JPH06343477A (es)
AT (1) ATE237693T1 (es)
CA (1) CA2124769C (es)
DE (2) DE4318387A1 (es)
DK (1) DK0632129T3 (es)
ES (1) ES2196014T3 (es)
PT (1) PT632129E (es)
SI (1) SI0632129T1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707091B1 (fr) 1993-06-30 1997-04-04 Cohen Haguenauer Odile Vecteur rétroviral pour le transfert et l'expression de gènes dans des cellules eucaryotes.
FR2727429B1 (fr) * 1994-11-30 1997-11-28 Haguenauer Odile Cohen Lignees d'encapsidation et vecteurs d'expression pour la transcomplementation de vecteurs retroviraux defectifs
DE19503082A1 (de) 1995-02-01 1996-08-08 Univ Ludwigs Albert Gegenstand und Verfahren zur bevorzugt transienten Expression und möglichen Translation spezifischer RNA im cytoplasmatischen Bereich höherer eukaryontischer Zellen
US5888767A (en) * 1996-11-27 1999-03-30 The Johns Hopkins University School Of Medicine Method of using a conditionally replicating viral vector to express a gene
CA2279673A1 (en) * 1995-12-15 1997-06-16 Enzo Therapeutics, Inc. Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acids for therapeutic and diagnostic uses
US6492165B1 (en) 1997-02-12 2002-12-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Retrovirus isolated from humans
US5882912A (en) * 1997-02-12 1999-03-16 Center For Disease Control And Prevention Retrovirus isolated from humans
US5929222A (en) * 1997-03-14 1999-07-27 Transgene S.A. Expression of a foamy virus envelope protein
WO2000024876A2 (en) 1998-10-27 2000-05-04 The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services Spumavirus isolated from humans
DE19858441C2 (de) * 1998-12-17 2001-02-15 Deutsches Krebsforsch FV-Vektoren zur Expression von Fremdgenen in Säugern und deren Verwendung
WO2000041732A1 (en) * 1999-01-19 2000-07-20 The Children's Hospital Of Philadelphia Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
US6800475B1 (en) 1999-06-14 2004-10-05 The United States Of America As Represented By The Department Of Health And Human Services Isolation of a human retrovirus
US20050244429A1 (en) * 2002-06-27 2005-11-03 Thomas Folks Live replicating spumavirus vector
US20080214437A1 (en) * 2002-09-06 2008-09-04 Mohapatra Shyam S Methods and compositions for reducing activity of the atrial natriuretic peptide receptor and for treatment of diseases
AU2003268531A1 (en) 2002-09-06 2004-03-29 University Of South Florida Materials and methods for treatment of allergic diseases
US8071560B2 (en) * 2004-02-17 2011-12-06 University Of South Florida Materials and methods for reducing inflammation by inhibition of the atrial natriuretic peptide receptor
EP1727556A2 (en) * 2004-02-17 2006-12-06 University Of South Florida Materials and methods for treatment of inflammatory and cell proliferation disorders
EP1750748A1 (en) * 2004-06-04 2007-02-14 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Use of the foamy virus bet protein for inactivating apobec
US10184942B2 (en) 2011-03-17 2019-01-22 University Of South Florida Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer
CN111093715A (zh) * 2017-09-18 2020-05-01 儿童医院医疗中心 强绝缘子和其在基因递送中的用途

Also Published As

Publication number Publication date
DE4318387A1 (de) 1994-12-08
ATE237693T1 (de) 2003-05-15
JP2007082562A (ja) 2007-04-05
DK0632129T3 (da) 2003-08-04
CA2124769A1 (en) 1994-12-04
EP0632129A1 (en) 1995-01-04
PT632129E (pt) 2003-08-29
EP0632129B1 (en) 2003-04-16
CA2124769C (en) 2007-07-10
JPH06343477A (ja) 1994-12-20
DE69432500T2 (de) 2003-11-20
SI0632129T1 (en) 2003-08-31
DE69432500D1 (de) 2003-05-22
US5646032A (en) 1997-07-08

Similar Documents

Publication Publication Date Title
ES2196014T3 (es) Vectores de virus espumosos recombinantes para usos medicos y de diagtico y procedimiento de preparacion de vectores de virus espumosos recombinantes.
ATE79649T1 (de) Herpes simplex-virus als vektor.
EE05138B1 (et) Rekombinantne MVA viirus ja selle kasutamine, isoleeritud eukarootne rakk, meetod rekombinantse HIV Nef-proteiini valmistamiseks ning vaktsiin
Ramsay et al. DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors
WO1995006743A3 (en) Methods and compositions for the large scale production of recombinant adeno-associated virus
CY1106513T1 (el) Λεντινοϊικο τριπλο dna και οχηματα και ανασυνδυασμενα κυτταρα που περιεχουν λεντινοϊικο τριπλο dna
CA2072627A1 (en) Recombinant herpes simplex viruses vaccines and methods
CA2104396A1 (en) Viral particles having altered host range
DK0784693T3 (da) Virusvektorer til genterapi
AU8067698A (en) Chimeric vectors comprising a phage packaging site and a portion derived from a genome of a eukaryotic virus
ATE284954T1 (de) Hyaluronan synthase gen und seine verwendung
CA2321964A1 (en) Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant virus
EP0261940A3 (en) Pseudorabies vaccines and dna vectors for recombination with pox viruses
HUT67962A (en) Microsomal triglyceride transfer protein
WO1998055639A3 (fr) Vecteurs adenoviraux recombinants comprenant une sequence d'epissage
KR0181976B1 (ko) 미생물의 세포, 조직 또는 숙주 지향성을 변화시키는 방법, 이 방법으로 수득된 재조합 미생물, 및 의학 및 수의학 분야에서 이들을 사용하는 방법
EP2044950A3 (en) Attenuated VIF DNA immunization cassettes for genetic vaccines
WO1994013812A3 (en) Novel entomopoxvirus genes, proteins and methods of use thereof
DK0843731T3 (da) Adenovirusvektorer til genterapi
NO922728L (no) Vaksine mot coccidiose
AU4334193A (en) Infectious bovine rhinotracheitis virus mutants and vaccines
DK498387A (da) Virus-dna-sekvens
ATE227775T1 (de) Impfstoff-vektoren von rekombinantem katzen- herpesvirus
BR9806084A (pt) Vetor de poliovirus sabin tipo i, recombinante ou quimérico de replicação competente, seus métodos de produção e célula hospedeira
WO1992014818A3 (en) Entomopoxvirus expression system comprising spheroidin or thymidine-kinase sequences